RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,380,410 | +156690.8% | 3,073,100 | +4.1% | 1.16% | +34.9% |
| Q1 2023 | $2,156 | -66.4% | 2,953,100 | -31.5% | 0.86% | -67.4% |
| Q4 2022 | $6,425 | -99.9% | 4,312,400 | +34.4% | 2.64% | -12.0% |
| Q3 2022 | $5,231,000 | +103.8% | 3,209,400 | -0.6% | 3.00% | +105.5% |
| Q2 2022 | $2,567,000 | -65.7% | 3,229,500 | -22.4% | 1.46% | -53.6% |
| Q1 2022 | $7,493,000 | +4.2% | 4,162,500 | -1.0% | 3.15% | +29.0% |
| Q4 2021 | $7,189,000 | +0.6% | 4,204,000 | +21.2% | 2.44% | -8.0% |
| Q3 2021 | $7,143,000 | +11.9% | 3,467,600 | +25.5% | 2.66% | +14.8% |
| Q2 2021 | $6,383,000 | +148.7% | 2,763,400 | -14.4% | 2.32% | +58.3% |
| Q2 2020 | $2,567,000 | – | 3,229,500 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |